Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN Study | stella

Learn Find trials matched to me

Learn Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy For Researchers Data Labs ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN Study | stella

Back to Diabetes Mellitus, Type 1 trials

Completed

Plain-English translation of NCT02632747 on ClinicalTrials.gov ↗ · Source last updated July 2020 · How we translate trials

Read our Type 1 diabetes research guide →

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(1 site)

Canada

Toronto General Hospital, Toronto, Ontario

Results

Read the full plain-English summary of this trial →

Key details

Phase

Testing effectiveness

Sponsor

Boehringer Ingelheim

Collaborators

Eli Lilly and Company

Enrollment target

~31 participants

Started

May 2016

Primary completion

December 2017

Age range

View full record on ClinicalTrials.gov

18 Years and older

Last updated on clinicaltrials.gov in July 2020.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.